NO171592C - Fremgangsmaate for fremstilling av aktive cinnolin-derivater - Google Patents
Fremgangsmaate for fremstilling av aktive cinnolin-derivaterInfo
- Publication number
- NO171592C NO171592C NO862141A NO862141A NO171592C NO 171592 C NO171592 C NO 171592C NO 862141 A NO862141 A NO 862141A NO 862141 A NO862141 A NO 862141A NO 171592 C NO171592 C NO 171592C
- Authority
- NO
- Norway
- Prior art keywords
- cinnolin
- derivatives
- procedure
- active
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB858513639A GB8513639D0 (en) | 1985-05-30 | 1985-05-30 | Cinnoline compounds |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO862141L NO862141L (no) | 1986-12-01 |
| NO171592B NO171592B (no) | 1992-12-28 |
| NO171592C true NO171592C (no) | 1993-04-07 |
Family
ID=10579908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO862141A NO171592C (no) | 1985-05-30 | 1986-05-29 | Fremgangsmaate for fremstilling av aktive cinnolin-derivater |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US4886800A (pl) |
| EP (1) | EP0205272B1 (pl) |
| JP (1) | JPH0713062B2 (pl) |
| KR (1) | KR900004402B1 (pl) |
| CN (1) | CN1014060B (pl) |
| AR (1) | AR242026A1 (pl) |
| AT (1) | ATE66215T1 (pl) |
| AU (1) | AU592086B2 (pl) |
| CA (1) | CA1309406C (pl) |
| DE (1) | DE3680828D1 (pl) |
| DK (1) | DK162221C (pl) |
| ES (3) | ES8801803A1 (pl) |
| FI (1) | FI85584C (pl) |
| GB (2) | GB8513639D0 (pl) |
| GR (1) | GR861411B (pl) |
| HU (1) | HU199433B (pl) |
| IE (1) | IE58782B1 (pl) |
| IL (1) | IL78992A0 (pl) |
| MW (1) | MW4386A1 (pl) |
| NO (1) | NO171592C (pl) |
| PH (1) | PH23518A (pl) |
| PL (1) | PL149227B1 (pl) |
| PT (1) | PT82678B (pl) |
| SU (1) | SU1500158A3 (pl) |
| ZA (1) | ZA863664B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8702288D0 (en) * | 1987-02-02 | 1987-03-11 | Erba Farmitalia | Cinnoline-carboxamides |
| US4925844A (en) * | 1988-02-09 | 1990-05-15 | Ici Americas Inc. | Antagonizing the pharmacological effects of a benzodiazepine receptor agonist |
| ES2051996T3 (es) * | 1988-02-09 | 1994-07-01 | Ici America Inc | Producto farmaceutico. |
| US5620978A (en) * | 1994-01-03 | 1997-04-15 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/NMDA receptor |
| CA2399991A1 (en) | 2000-03-21 | 2001-09-27 | Pharmacia & Upjohn Company | 4-hydroxy-1,8-naphthyridine-3-carboxamides as antiviral agents |
| JP2003528087A (ja) | 2000-03-21 | 2003-09-24 | ファルマシア・アンド・アップジョン・カンパニー | 抗ウイルス剤としての4−オキソ−1,4−ジヒドロ−3−シンノリンカルボキサミド |
| NZ521522A (en) | 2000-03-21 | 2004-08-27 | Upjohn Co | 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides useful as antiviral agents |
| JP2003531195A (ja) | 2000-03-21 | 2003-10-21 | ファルマシア・アンド・アップジョン・カンパニー | 抗ウイルス剤としての4−ヒドロキシシンノリン−3−カルボキサミド |
| AU2006327300A1 (en) * | 2005-12-20 | 2007-06-28 | Astrazeneca Ab | Substituted Cinnoline derivatives as GABAa-receptor modulators and method for their synthesis |
| US7465795B2 (en) * | 2005-12-20 | 2008-12-16 | Astrazeneca Ab | Compounds and uses thereof |
| AR067028A1 (es) * | 2007-06-19 | 2009-09-30 | Astrazeneca Ab | Compuestos y usos de los mismos 849 |
| WO2010123441A1 (en) * | 2009-04-21 | 2010-10-28 | Astrazeneca Ab | Crystalline form of 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n-propylcinnoline-3- carboxamide hydrogen sulphate, for treatment of anxiety disorders |
| WO2010123443A1 (en) * | 2009-04-21 | 2010-10-28 | Astrazeneca Ab | Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate. |
| WO2010123440A1 (en) * | 2009-04-21 | 2010-10-28 | Astrazeneca Ab | Pharmaceutical composition comprising 4-amino-8-(2-fluoro-6-methoxy-phenyl)-n- propylcinnoline-3-carboxamide hydrogen sulphate and rate-controlling polymer |
| AU2012258977A1 (en) | 2011-05-23 | 2014-01-16 | Imago Pharmaceuticals, Inc. | Inhibitors of LRRK2 kinase activity |
| CN111905828B (zh) * | 2020-08-24 | 2022-04-19 | 万华化学集团股份有限公司 | 一种萘基配体mof活性炭复合催化剂及其制备方法和用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3657241A (en) * | 1970-03-12 | 1972-04-18 | Dow Chemical Co | Substituted cinnoline compounds |
| GB1306839A (en) * | 1970-10-16 | 1973-02-14 | Ici Ltd | Pharmaceutical compositions |
| GB1474399A (en) * | 1974-08-19 | 1977-05-25 | Ici Ltd | Cinnolin-3-yl carboxylic acids and derivatives thereof |
| GB1472766A (en) * | 1974-11-07 | 1977-05-04 | Ici Ltd | Hydroxycinnoline derivatives processes for their preparation and their use in pharmaceutical compositions |
| US4085103A (en) * | 1974-11-07 | 1978-04-18 | Imperial Chemical Industries Limited | 6-Substituted-4-hydroxycinnolin-3-yl-carboxylic acids and esters thereof |
| DD123525A1 (pl) * | 1976-02-10 | 1977-01-05 | ||
| US4379929A (en) * | 1981-03-19 | 1983-04-12 | Eli Lilly And Company | 4(1H)-Oxocinnoline-3-carboxylic acid derivatives |
| US4729782A (en) * | 1983-09-14 | 1988-03-08 | Lafarge Coppee | Pollen suppressant comprising a fused pyridazinone |
| GB8702288D0 (en) * | 1987-02-02 | 1987-03-11 | Erba Farmitalia | Cinnoline-carboxamides |
-
1985
- 1985-05-30 GB GB858513639A patent/GB8513639D0/en active Pending
-
1986
- 1986-05-09 GB GB868611419A patent/GB8611419D0/en active Pending
- 1986-05-13 IE IE126786A patent/IE58782B1/en not_active IP Right Cessation
- 1986-05-16 ZA ZA863664A patent/ZA863664B/xx unknown
- 1986-05-20 PH PH33792A patent/PH23518A/en unknown
- 1986-05-22 AU AU57819/86A patent/AU592086B2/en not_active Ceased
- 1986-05-23 AT AT86303963T patent/ATE66215T1/de not_active IP Right Cessation
- 1986-05-23 DE DE8686303963T patent/DE3680828D1/de not_active Expired - Lifetime
- 1986-05-23 EP EP86303963A patent/EP0205272B1/en not_active Expired - Lifetime
- 1986-05-28 HU HU862243A patent/HU199433B/hu not_active IP Right Cessation
- 1986-05-29 SU SU864027693A patent/SU1500158A3/ru active
- 1986-05-29 US US06/868,791 patent/US4886800A/en not_active Expired - Lifetime
- 1986-05-29 NO NO862141A patent/NO171592C/no unknown
- 1986-05-29 CA CA000510335A patent/CA1309406C/en not_active Expired - Lifetime
- 1986-05-30 CN CN86104358A patent/CN1014060B/zh not_active Expired
- 1986-05-30 AR AR86304166A patent/AR242026A1/es active
- 1986-05-30 PT PT82678A patent/PT82678B/pt unknown
- 1986-05-30 KR KR1019860004274A patent/KR900004402B1/ko not_active Expired
- 1986-05-30 JP JP61123840A patent/JPH0713062B2/ja not_active Expired - Lifetime
- 1986-05-30 ES ES555546A patent/ES8801803A1/es not_active Expired
- 1986-05-30 PL PL1986259791A patent/PL149227B1/pl unknown
- 1986-05-30 DK DK256386A patent/DK162221C/da not_active IP Right Cessation
- 1986-05-30 GR GR861411A patent/GR861411B/el unknown
- 1986-05-30 MW MW43/86A patent/MW4386A1/xx unknown
- 1986-05-30 FI FI862315A patent/FI85584C/fi not_active IP Right Cessation
- 1986-06-02 IL IL78992A patent/IL78992A0/xx not_active IP Right Cessation
-
1987
- 1987-04-30 ES ES557522A patent/ES8801903A1/es not_active Expired
- 1987-12-16 ES ES557790A patent/ES8802611A1/es not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO841568L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater | |
| NO163406C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinolinonderivater. | |
| NO163227C (no) | Fremgangsm te for fremstilling av 1-substituert-aryihydro-4-oksonaftyridin-derivater. | |
| NO170480C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoksyeddiksyre-derivater | |
| NO862477D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-arylimidazol-derivater. | |
| NO864425L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyl-oksoftalazinyl-eddiksyre-derivater | |
| NO862650L (no) | Fremgangsmaate for fremstilling av isoksazol- og furanderivater. | |
| NO862956D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrimidin-derivater. | |
| NO167026C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO865013D0 (no) | Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater. | |
| NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
| NO169014C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive distamycinderivater | |
| NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
| NO864110L (no) | Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater. | |
| NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
| NO171592C (no) | Fremgangsmaate for fremstilling av aktive cinnolin-derivater | |
| NO841542L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater | |
| NO863251D0 (no) | Fremgangsmaate for fremstilling av sphingosinderivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO860429L (no) | Fremgangsmaate for fremstilling av imidazolyl-indol-derivater. | |
| NO865012D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive benzazepinderivater. | |
| NO864101L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO171108C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-desmetyl-mevalonsyrederivater | |
| NO842821L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater |